国际足联反兴奋剂报告2024-2025医药生物2025-10-03FIFA程***AI智能总结查看更多FIFA 在 2024 年 1 月 1 日至 2025 年 7 月 31 日期间的反兴奋剂工作主要集中在赛事检测和与各大洲足联的合作上。报告期内共进行了 1,942 次兴奋剂检测，其中 1,340 次在赛事期间进行（in-competition），602 次在赛事之外进行（out-of-competition）。共收集了 2,367 份样本，其中尿液样本占 82%（1,946 份），血液样本占 18%（421 份）。检测覆盖了 160 个 FIFA 会员协会，占会员协会总数的 76%。报告期内仅发现 2 例阳性结果，阳性率为 0.10%，另有 1 例异常结果（0.05%）。
FIFA 的检测工作主要围绕其举办的赛事展开，包括 2024 年的沙滩足球世界杯、U-20 女子世界杯、室内足球世界杯、U-17 女子世界杯、跨洲杯、FIFAe 赛事以及 2025 年的沙滩足球世界杯和俱乐部世界杯。其中，FIFA 俱乐部世界杯对所有参赛球队进行了赛前检测，共收集 1,159 份样本。此外，FIFA 还与各大洲足联合作开展反兴奋剂工作，其中与 CONCACAF 的合作在 2024 年检测数量同比增长 1,160%，2025 年前 7 个月已进行 272 次检测；与 OFC 的合作在 2025 年检测数量同比增长 1,800%，已进行 228 次检测。
Contents
1. Foreword3
2. Glossary4
3. Methodology6
4. Sample and test collections: summary7
a. Total number of tests7b. Type of samples7c. Timing of tests8d. Distribution of tests by month9e. Distribution of tests by gender10f. Distribution of tests by age10g. Tests by FIFA Member Association11h. World Anti-Doping Agency-accredited laboratories12i.Number of adverse analytical findings and anti-doping rule violations13
5. Test distribution: competitions14
a. FIFA Beach Soccer World Cup UAE 2024 Dubai14b. FIFA U-20 Women’s World Cup Colombia 202415c. FIFA Futsal World Cup Uzbekistan 202416d. FIFA U-17 Women’s World Cup Dominican Republic 202417e. FIFA Intercontinental Cup 202418f. FIFAe competitions19g. FIFA Beach Soccer World Cup Seychelles 202520h. FIFA Club World Cup 202521i. Preliminary competitions for the FIFA World Cup 2622
6. Collaborations with confederations23
a. Ongoing collaboration with Concacaf23b. Collaboration with the OFC24
7. General disclaimer25
1. Foreword
FIFA remains firmly committed to ensuring that the outcome of all competitionsand matches organised by FIFA and its stakeholders owes purely to sporting merit.As highlighted in the FIFA Anti-Doping Regulations, the fundamental aims of dopingcontrol are threefold. They are to: a) safeguard the physical health and mental integrityof players; b) uphold and preserve the ethics of sport; and c) ensure that all competitorshave an equal chance.
As part of FIFA’s objective to provide transparency in relation to its anti-dopingactivities, this report, which covers the period between 1 January 2024 and 31July2025,offers a summary of FIFA’s efforts to collect and test anti-doping samples.
There was a change of scenery for the FIFA Anti-Doping Unit in August 2024, when itrelocated to Miami, United States. The unit oversaw many anti-doping missions fromits new base, including in- and out-of-competition testing across the following nineevents:
• FIFA Beach Soccer World Cup UAE 2024 Dubai• FIFA U-20 Women’s World Cup Colombia 2024• FIFA Futsal World Cup Uzbekistan 2024• FIFA U-17 Women’s World Cup Dominican Republic 2024• FIFA Intercontinental Cup 2024• FIFAe Next Gen 2024• FIFAe Finals 2024• FIFA Beach Soccer World Cup Seychelles 2025• FIFA Club World Cup 2025
FIFA’s anti-doping efforts are not just about testing and enforcement; they alsopromote a values-based culture of respect, fairness and integrity across the game.
During the reporting period, FIFA continued to support the six continentalconfederations with the delivery of their anti-doping programmes, as illustrated by itsongoing and expanded collaboration with Concacaf and its work with the OFC.
Carlos SchneiderDirector of Judicial BodiesEmilio García SilveroChief Legal & Compliance Officer
2. Glossary
Anti-Doping Administration and Management System: A web-based databasemanagement tool for data entry, storage-sharing and reporting designed to assiststakeholders and the World Anti-Doping Agency in their anti-doping operations inconjunction with data protection legislation.
Adverse analytical finding: A report from a World Anti-Doping Agency-accreditedlaboratory or other World Anti-Doping Agency-approved laboratory that, consistentwith the International Standard for Laboratories, establishes in a sample the presenceof a prohibited substance or its metabolites or markers or evidence of the use of aprohibited method.
Anti-doping activities: Anti-doping education and information, test distributionplanning, maintaining a registered testing pool, managing athlete biological passports,conducting testing, organising the analysis of samples, gathering intelligence andconducting investigations, processing of therapeutic use exemption applications,results management, hearings, monitoring and enforcing compliance with anyconsequences imposed, and all other activities related to anti-doping to be carried outby or on behalf of an anti-doping organisation, as set out in the World Anti-DopingAgency Code and/or the international standards.
Anti-doping organisation: The World Anti-Doping Agency or a signatory thatis responsible for adopting rules for initiating, implementing or enforcing any partof the doping control process. This includes, other major event organisations thatconduct testing at their events, international federations and national anti-dopingorganisations.
Atypical finding: A report from a World Anti-Doping Agency-accredited laboratoryor other World Anti-Doping Agency-approved laboratory that requires furtherinvestigation as provided by the International Standard for Laboratories or relatedtechnical documents prior to the determination of an adverse analytical finding.
Confederation: A group of Member Associations that are recognised by FIFA asbelonging to the same continent (or assimilable geographical region).
Doping: The occurrence of one or more of the anti-doping rule violations set forth inthe FIFA Anti-Doping Regulations.
Doping control: All steps and processes i
点击免费查看完整报告